Petra Hamerlik

Company: AstraZeneca

Job title: Director

Seminars:

Targeting DNA Repair in Glioblastoma: New Era of Brain Penetrant Agents 8:10 am

Aberrant DNA repair in malignant gliomas Functional interplay between cancer cell metabolism and DNA repair Brain penetrant DNA repair inhibitor efficacy in malignant gliomasRead more

day: Day Two